Skip to main content
Journal of the Egyptian National Cancer Institute

Table 3 Comparison between the two studied periods according to hematologic parameters in each group

From: Intermittent fasting during adjuvant chemotherapy may promote differential stress resistance in breast cancer patients

Hematologic parameters

Intermittent fasting (n = 24)

Non-fasting (n = 24)

Baseline

After cycle 4

P

Baseline

After cycle 4

P

RBC (× 106/µl)

4.89 ± 0.45

4.61 ± 0.53

(0.004**)

4.99 ± 0.45

4.61 ± 0.72

(0.016*)

HG (g/dl)

12.35 ± 1.45

11.65 ± 1.27

(0.001**)

12.36 ± 1.19

11.89 ± 1.30

(0.002**)

PLT (× 103/µl)

317.5 ± 73.23

383.6 ± 79.85

(< 0.001***)

309.71 ± 112.41

376.04 ± 119.97

(0.009**)

WBC (× 103/µl)

8.33 ± 2.92

5.87 ± 1.87

(< 0.001***)

6.54 ± 1.44

5.98 ± 2.33

(0.152)

NEUT (× 103/mm3)

5.08 ± 2.82

3.45 ± 1.46

(< 0.001***)

3.54 ± 1.07

3.76 ± 1.65

(0.493)

  1. RBC red blood cells, HG hemoglobin, PLT platelets, WBC white blood cells, NEUT, neutrophils
  2. Data presented as mean ± SD. P P-value for comparing between baseline and after cycle 4 in each group
  3. *P < 0.05
  4. **P < 0.01
  5. ***P < 0.001
Back to article page